Pfizer, Merck, Eaton, Cummins and Time Warner are part of Zacks Earnings Preview PR Newswire CHICAGO, July 29, 2013 CHICAGO, July 29, 2013 /PRNewswire/ --Zacks.com releases the list of companies likely to issue earnings surprises. This week's list includes Pfizer (NYSE:PFE-Free Report),Merck (NYSE:MRK-Free Report),Eaton Corp (NYSE:ETN-Free Report), Cummins (NYSE:CMI-Free Report), Time Warner (NYSE:TWX-Free Report). (Logo: http://photos.prnewswire.com/prnh/20101027/ZIRLOGO) To see more earnings analysis, visit http://at.zacks.com/?id=3207. Every day, Zacks.com makes their Bull Stock of the Day available, free of charge. To see it, click here. Grading the Q2 Earnings Season We have crossed the halfway mark in the Q2 earnings season – with results from 262 S&P 500 companies, accounting for 59.3% of the index's total market capitalization, already out (as of Friday, July 26th). In other words, while there are still plenty of reports to come, we have seen roughly two-thirds of Q2 earnings already. This week brings in results from 808 companies, including 125 S&P 500 members. This includes operators likePfizer (NYSE:PFE-Free Report),Merck (NYSE:MRK-Free Report),Eaton Corp (NYSE:ETN-Free Report), Cummins (NYSE:CMI-Free Report), Time Warner (NYSE:TWX-Free Report), and many others. By the end of this week, we will have seen Q2 earnings reports from 77% of the S&P 500 members. We have seen enough Q2 earnings reports by now to be able to judge it with a fair amount of confidence. So what is the judgment then? Looking at the aggregate growth rates, beat ratios, and median surprises, the Q2 earnings season isn't materially different from what we saw in Q1 and over the last few earnings seasons. While we had graded the Q1 earnings season as between 'average' and 'below average', the Q2 earnings season appears to be tracking better than Q1 on the revenue beat ratio. Before buying into the not-so-bad earnings narrative, we should keep in mind that strong numbers from the Finance sector are playing an outsized role in giving respectability to the aggregate earnings data. One could dispute the legitimacy of the strength in Finance earnings given the not-so-small contribution of reserve releases to bank earnings. But even keeping this issue aside, there is no dispute about the broad weakness outside of the Finance sector. Given this broad-based growth weakness, I would give the Q2 earnings season a 'below average' grade, even though total earnings for the quarter will likely reach a new all-time record. The Q2 Earnings Scorecard Total earnings for these 262 companies are up +3.7%, with 65.3% beating earnings expectations and a median surprise of +2.5%. On the revenue side, we have a growth rate of +3.6% and 51.9% are coming ahead of top-line expectations with a median surprise of +0.2%. The earnings growth rate of +3.7% compares to +2.5% earnings growth rate in Q1 and the 4-quarter average growth pace of +3.8% for the same set of 262 companies. The earnings beat ratio, however, is tracking lower– 65.3% in Q2 vs. 68.3% in Q1 and the 4-quarter average of 66.5%. On the revenue side, the growth of +3.6% compares to +3% in Q1 and the 4-quarter average of +3.1% for this group of 262 companies. The revenue beat ratio of 51.9%, however, is decidedly better than what we saw in Q1 (42%) and the 4-quarter average (46.1%). About the Zacks Rank Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." Since inception in 1988, #1 Rank stocks have generated an average annual return of +28%. During the 2000-2002 bear market, Zacks #1 Rank stocks gained +43.8%, while the S&P 500 tumbled -37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have significantly underperformed the S&P 500 (+3% versus +10%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively. Zacks "Profit from the Pros" e-mail newsletter offers continuous coverage of the industries and the stocks poised to outperform the market. Click to subscribe to this free newsletter today. About Zacks Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros. Get the full Report on PFE - FREE Get the full Report on MRK - FREE Get the full Report on ETN - FREE Get the full Report on CMI - FREE Get the full Report on TWI - FREE Follow us on Twitter: http://twitter.com/zacksresearch Join us on Facebook: http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates. Media Contact Zacks Investment Research 800-767-3771 ext. 9339 email@example.com http://www.zacks.com Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer. Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumedthat any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein andis subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release. SOURCE Zacks Investment Research, Inc. Website: http://www.zacks.com
Pfizer, Merck, Eaton, Cummins and Time Warner are part of Zacks Earnings Preview
Press spacebar to pause and continue. Press esc to stop.